Gregory Everson

Gregory Everson

Company: HepQuant

Job title: Managing Director & CEO


Progressing towards a Sensitive and Reliable Endpoint for Treatment Efficacy 11:00 am

• New Data from Clinical Trials (response to new pharma therapy, reproducibility, progression to decomp in cirrhosis, portal hypertension) • Pivotal Study and Regulatory Progress • Anticipated Timelines for Clinical Trial and Commercial Scale-upRead more

day: Day 1 Stream 3 AM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.